(3S)-5-(trifluoromethoxy)-2,3-dihydrobenzo[b]furan-3-ylamine hcl
95%
- Product Code: 36771
CAS:
2177264-44-5
| Molecular Weight: | 255.6200 g./mol | Molecular Formula: | C₉H₉ClF₃NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD24435459 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a trifluoromethoxy group and a dihydrobenzofuran moiety, makes it a valuable intermediate in the creation of compounds targeting central nervous system disorders. It is often explored for its potential in developing drugs that modulate neurotransmitter activity, such as serotonin or dopamine receptors, which are crucial in treating conditions like depression, anxiety, and Parkinson's disease. Additionally, its unique chemical properties are leveraged in the design of molecules with enhanced bioavailability and metabolic stability, making it a key component in the optimization of drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $676.69 |
+
-
|
(3S)-5-(trifluoromethoxy)-2,3-dihydrobenzo[b]furan-3-ylamine hcl
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a trifluoromethoxy group and a dihydrobenzofuran moiety, makes it a valuable intermediate in the creation of compounds targeting central nervous system disorders. It is often explored for its potential in developing drugs that modulate neurotransmitter activity, such as serotonin or dopamine receptors, which are crucial in treating conditions like depression, anxiety, and Parkinson's disease. Additionally, its unique chemical properties are leveraged in the design of molecules with enhanced bioavailability and metabolic stability, making it a key component in the optimization of drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :